Lawrence Williams

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Procedures

Concepts & Ideas

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bading James R; Hörling Magnus; Williams Lawrence E; Colcher David; Raubitschek Andrew; Strand Sven E
Quantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice.
Williams Lawrence E; DeNardo Gerald L; Meredith Ruby F
Targeted radionuclide therapy.
Williams Lawrence E
Anniversary paper: nuclear medicine: fifty years and still counting.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Lawrence Williams (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Bading James R; Hörling Magnus; Williams Lawrence E; Colcher David; Raubitschek Andrew; Strand Sven E
Quantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice.
Cancer biotherapy & radiopharmaceuticals 2008;23(4):399-409.
2008: Williams Lawrence E; DeNardo Gerald L; Meredith Ruby F
Targeted radionuclide therapy.
Medical physics 2008;35(7):3062-8.
2008: Williams Lawrence E
Anniversary paper: nuclear medicine: fifty years and still counting.
Medical physics 2008;35(7):3020-9.
2008: Li Lin; Bading James; Yazaki Paul J; Ahuja Amitkumar H; Crow Desiree; Colcher David; Williams Lawrence E; Wong Jeffrey Y C; Raubitschek Andrew; Shively John E
A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies.
Bioconjugate chemistry 2008;19(1):89-96.
2007: Cai Weibo; Olafsen Tove; Zhang Xianzhong; Cao Qizhen; Gambhir Sanjiv S; Williams Lawrence E; Wu Anna M; Chen Xiaoyuan
PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(2):304-10.
2007: Kenanova Vania; Olafsen Tove; Williams Lawrence E; Ruel Nora H; Longmate Jeffrey; Yazaki Paul J; Shively John E; Colcher David; Raubitschek Andrew A; Wu Anna M
Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy.
Cancer research 2007;67(2):718-26.
2006: Wong Jeffrey Y C; Chu David Z; Williams Lawrence E; Liu An; Zhan Jiping; Yamauchi Dave M; Wilczynski Sharon; Wu Anna M; Yazaki Paul J; Shively John E; Leong Lucille; Raubitschek Andrew A
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
Cancer biotherapy & radiopharmaceuticals 2006;21(2):88-100.
2006: Li Lin; Yazaki Paul J; Anderson Anne-Line; Crow Desiree; Colcher David; Wu Anna M; Williams Lawrence E; Wong Jeffrey Y C; Raubitschek Andrew; Shively John E
Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.
Bioconjugate chemistry 2006;17(1):68-76.
2005: Olafsen Tove; Kenanova Vania E; Sundaresan Gobalakrishnan; Anderson Anne-Line; Crow Desiree; Yazaki Paul J; Li Lin; Press Michael F; Gambhir Sanjiv S; Williams Lawrence E; Wong Jeffrey Y C; Raubitschek Andrew A; Shively John E; Wu Anna M
Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.
Cancer research 2005;65(13):5907-16.
2005: Kenanova Vania; Olafsen Tove; Crow Desiree M; Sundaresan Gobalakrishnan; Subbarayan Murugesan; Carter Nora H; Ikle David N; Yazaki Paul J; Chatziioannou Arion F; Gambhir Sanjiv S; Williams Lawrence E; Shively John E; Colcher David; Raubitschek Andrew A; Wu Anna M
Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.
Cancer research 2005;65(2):622-31.
2004: Wong Jeffrey Y C; Chu David Z; Williams Lawrence E; Yamauchi Dave M; Ikle David N; Kwok Cheuk S; Liu An; Wilczynski Sharon; Colcher David; Yazaki Paul J; Shively John E; Wu Anna M; Raubitschek Andrew A
Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5014-21.
2004: Yazaki Paul J; Sherman Mark A; Shively John E; Ikle David; Williams Lawrence E; Wong Jeffrey Y C; Colcher David; Wu Anna M; Raubitschek Andrew A
Humanization of the anti-CEA T84.66 antibody based on crystal structure data.
Protein engineering, design & selection : PEDS 2004;17(5):481-9.
2004: Olafsen Tove; Tan Giselle J; Cheung Chia-Wei; Yazaki Paul J; Park Jinha M; Shively John E; Williams Lawrence E; Raubitschek Andrew A; Press Michael F; Wu Anna M
Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting.
Protein engineering, design & selection : PEDS 2004;17(4):315-23.
2004: Olafsen Tove; Cheung Chia-Wei; Yazaki Paul J; Li Lin; Sundaresan Gobalakrishnan; Gambhir Sanjiv S; Sherman Mark A; Williams Lawrence E; Shively John E; Raubitschek Andrew A; Wu Anna M
Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications.
Protein engineering, design & selection : PEDS 2004;17(1):21-7.
2003: Wong Jeffrey Y C; Shibata Stephen; Williams Lawrence E; Kwok Cheuk S; Liu An; Chu David Z; Yamauchi Dave M; Wilczynski Sharon; Ikle David N; Wu Anna M; Yazaki Paul J; Shively John E; Doroshow James H; Raubitschek Andrew A
A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5842-52.
2003: Sundaresan Gobalakrishnan; Yazaki Paul J; Shively John E; Finn Ronald D; Larson Steven M; Raubitschek Andrew A; Williams Lawrence E; Chatziioannou Arion F; Gambhir Sanjiv S; Wu Anna M
124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(12):1962-9.
2002: Williams Lawrence E; Liu An; Yamauchi Dave M; Lopatin George; Raubitschek Andrew A; Wong Jeffrey Y C
The two types of correction of absorbed dose estimates for internal emitters.
Cancer 2002;94(4 Suppl):1231-4.
2001: Williams L E; Beatty B G; Shively J E; Beatty J D
Accumulation of radiolabeled anti-CEA antibody (mT84.66) in the case of multiple LS174T tumors in a nude mouse model.
Cancer biotherapy & radiopharmaceuticals 2001;16(2):147-57.
2001: Tsai S W; Li L; Williams L E; Anderson A L; Raubitschek A A; Shively J E
Metabolism and renal clearance of 111In-labeled DOTA-conjugated antibody fragments.
Bioconjugate chemistry 2001;12(2):264-70.
2001: Yazaki P J; Wu A M; Tsai S W; Williams L E; Ikler D N; Wong J Y; Shively J E; Raubitschek A A
Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
Bioconjugate chemistry 2001;12(2):220-8.
2001: Williams L E; Wu A M; Yazaki P J; Liu A; Raubitschek A A; Shively J E; Wong J Y
Numerical selection of optimal tumor imaging agents with application to engineered antibodies.
Cancer biotherapy & radiopharmaceuticals 2001;16(1):25-35.
2000: Wong JYC; Chu D Z; Yamauchi D M; Williams L E; Liu A; Wilczynski S; Wu A M; Shively J E; Doroshow J H; Raubitschek A A
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):3855-63.
2000: Xu X; Clarke P; Szalai G; Shively J E; Williams L E; Shyr Y; Shi E; Primus F J
Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Cancer research 2000;60(16):4475-84.
2000: Wu A M; Yazaki P J; Tsai S w; Nguyen K; Anderson A L; McCarthy D W; Welch M J; Shively J E; Williams L E; Raubitschek A A; Wong J Y; Toyokuni T; Phelps M E; Gambhir S S
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(15):8495-500.
2000: Williams L E; Liu A; Wu A M; Yazaki P J; Yamauchi D M; Lopatin G; Raubitschek A A; Wong J Y
Truncation of blood curves to enhance imaging and therapy with monoclonal antibodies.
Medical physics 2000;27(5):988-94.
2000: Tsai S W; Sun Y; Williams L E; Raubitschek A A; Wu A M; Shively J E
Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5.
Bioconjugate chemistry 2000;11(3):327-34.
2000: Szalai G; Williams L E; Primus F J
Tumor targeting with radiolabeled antibodies in a human carcinoembryonic antigen transgenic mouse model.
International journal of cancer. Journal international du cancer 2000;85(6):751-6.
2000: Wong J Y; Wang J; Liu A; Odom-Maryon T; Shively J E; Raubitschek A A; Williams L E
Evaluating changes in stable chromosomal translocation frequency in patients receiving radioimmunotherapy.
International journal of radiation oncology, biology, physics 2000;46(3):599-607.
1999: Wong J Y; Somlo G; Odom-Maryon T; Williams L E; Liu A; Yamauchi D; Wu A M; Yazaki P; Wilczynski S; Shively J E; Forman S; Doroshow J H; Raubitschek A A
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3224s-3231s.
1999: Williams L E; Liu A; Raubitschek A A; Wong J Y
A method for patient-specific absorbed dose estimation for internal beta emitters.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3015s-3019s.
1999: Liu A; Williams L E; Lopatin G; Yamauchi D M; Wong J Y; Raubitschek A A
A radionuclide therapy treatment planning and dose estimation system.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(7):1151-3.
1999: Clarke K G; Odom-Maryon T L; Williams L E; Liu A; Lopatin G; Chou J; Farino G M; Raubitschek A A; Wong J Y
Intrapatient consistency of imaging biodistributions and their application to predicting therapeutic doses in a phase I clinical study of 90Y-based radioimmunotherapy.
Medical physics 1999;26(5):799-809.
1998: Wong J Y; Chu D Z; Yamauchi D; Odom-Maryon T L; Williams L E; Liu A; Esteban J M; Wu A M; Primus F J; Beatty J D; Shively J E; Raubitschek A A
Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2097-104.
1998: Liu A; Williams L E; Wong J Y; Raubitschek A A
Monte Carlo-assisted voxel source kernel method (MAVSK) for internal beta dosimetry.
Nuclear medicine and biology 1998;25(4):423-33.
1998: Williams L E; Lewis M R; Bebb G G; Clarke K G; Odom-Maryon T L; Shively J E; Raubitschek A A
Biodistribution of 111In- and 90Y-labeled DOTA and maleimidocysteineamido-DOTA conjugated to chimeric anticarcinoembryonic antigen antibody in xenograft-bearing nude mice: comparison of stable and chemically labile linker systems.
Bioconjugate chemistry 1998;9(1):87-93.
1998: Szalai G; Williams L E; Clarke P E; Primus F J
A murine model system for detection of neoplasia of the head and neck using transfectomas and carcinoembryonic antigen transgenic mice.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 1998;255(5):271-4.
1997: Kaplan D D; Williams L E; Clarke K G; Odom-Maryon T L; Liu A; Lopatin G; Raubitschek A A; Wong J Y
Estimating residence times and their associated errors in patient absorbed-dose calculation.
Journal of nuclear medicine technology 1997;25(4):264-8.
1997: Odom-Maryon T L; Williams L E; Chai A; Lopatin G; Liu A; Wong Y C; Chou J; Clarke K G; Raubitschek A A
Pharmacokinetic modeling and absorbed dose estimation for chimeric anti-CEA antibody in humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(12):1959-66.
1997: Wong J Y; Thomas G E; Yamauchi D; Williams L E; Odom-Maryon T L; Liu A; Esteban J M; Neumaier M; Dresse S; Wu A M; Primus F J; Shively J E; Raubitschek A A
Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(12):1951-9.
1996: Hu S; Shively L; Raubitschek A; Sherman M; Williams L E; Wong J Y; Shively J E; Wu A M
Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.
Cancer research 1996;56(13):3055-61.
1996: Wu A M; Chen W; Raubitschek A; Williams L E; Neumaier M; Fischer R; Hu S Z; Odom-Maryon T; Wong J Y; Shively J E
Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.
Immunotechnology : an international journal of immunological engineering 1996;2(1):21-36.
1995: Williams L E; Liu A; Wu A M; Odom-Maryon T; Chai A; Raubitschek A A; Wong J Y
Figures of merit (FOMs) for imaging and therapy using monoclonal antibodies.
Medical physics 1995;22(12):2025-7.
1995: Wong J Y; Williams L E; Yamauchi D M; Odom-Maryon T; Esteban J M; Neumaier M; Wu A M; Johnson D K; Primus F J; Shively J E
Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.
Cancer research 1995;55(23 Suppl):5929s-5934s.
1995: Williams L E; Odom-Maryon T L; Liu A; Chai A; Raubitschek A A; Wong J Y; D'Argenio D Z
On the correction for radioactive decay in pharmacokinetic modeling.
Medical physics 1995;22(10):1619-26.
1994: Liu A; Williams L E; Demidecki A J; Raubitschek A A; Wong J Y
Modeling of tumor uptake to determine the time-dose-fractionation effect in radioimmunotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(9):1561-4.
1994: Beatty B G; Kuhn J A; Hui T E; Fisher D R; Williams L E; Beatty J D
Application of the cross-organ beta dose method for tissue dosimetry in tumor-bearing mice treated with a 90Y-labeled immunoconjugate.
Cancer 1994;73(3 Suppl):958-65.
1994: Hui T E; Fisher D R; Kuhn J A; Williams L E; Nourigat C; Badger C C; Beatty B G; Beatty J D
A mouse model for calculating cross-organ beta doses from yttrium-90-labeled immunoconjugates.
Cancer 1994;73(3 Suppl):951-7.
1994: Buras R; Williams L E; Beatty B G; Wong J Y; Beatty J D; Wanek P M
A method including edge effects for the estimation of radioimmunotherapy absorbed doses in the tumor xenograft model.
Medical physics 1994;21(2):287-92.
1993: Beatty B G; Paxton R J; Hawthorne M F; Williams L E; Rickard-Dickson K J; Do T; Shively J E; Beatty J D
Pharmacokinetics of an anti-carcinoembryonic antigen monoclonal antibody conjugated to a bifunctional transition metal carborane complex (venus flytrap cluster) in tumor-bearing mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(8):1294-302.
1993: Demidecki A J; Williams L E; Wong J Y; Wessels B W; Yorke E D; Strandh M; Strand S E
Considerations on the calibration of small thermoluminescent dosimeters used for measurement of beta particle absorbed doses in liquid environments.
Medical physics 1993;20(4):1079-87.
1993: Williams L E; Bares R B; Fass J; Hauptmann S; Schumpelick V; Buell U
Uptake of radiolabeled anti-CEA antibodies in human colorectal primary tumors as a function of tumor mass.
European journal of nuclear medicine 1993;20(4):345-7.
1993: Yorke E D; Williams L E; Demidecki A J; Heidorn D B; Roberson P L; Wessels B W
Multicellular dosimetry for beta-emitting radionuclides: autoradiography, thermoluminescent dosimetry and three-dimensional dose calculations.
Medical physics 1993;20(2 Pt 2):543-50.
1993: Buras R R; Wong J Y; Kuhn J A; Beatty B G; Williams L E; Wanek P M; Beatty J D
Comparison of radioimmunotherapy and external beam radiotherapy in colon cancer xenografts.
International journal of radiation oncology, biology, physics 1993;25(3):473-9.
1992: Wilson L A; Kuhn J A; Corbisiero R M; Smith M; Beatty J D; Williams L E; Rusnak M; Kondo R L; Demidecki A J
A technical analysis of an intraoperative radiation detection probe.
Medical physics 1992;19(5):1219-23.
1992: Kuhn J A; Wong J Y; Beatty B G; Esteban J M; Williams L E; Beatty J D
Gamma-interferon enhancement of carcinoembryonic antigen expression in human colon carcinoma xenografts.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;11(4):257-66.
1991: Corbisiero R M; Yamauchi D M; Williams L E; Esteban J M; Odom-Maryon T; Beatty J D
Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis.
Cancer research 1991;51(20):5704-11.
1991: Kuhn J A; Beatty B G; Wong J Y; Esteban J M; Wanek P M; Wall F; Buras R R; Williams L E; Beatty J D
Interferon enhancement of radioimmunotherapy for colon carcinoma.
Cancer research 1991;51(9):2335-9.
1991: Paxton R J; Beatty B G; Hawthorne M F; Varadarajan A; Williams L E; Curtis F L; Knobler C B; Beatty J D; Shively J E
A transition metal complex (Venus flytrap cluster) for radioimmunodetection and radioimmunotherapy.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(8):3387-91.
1991: Wong J Y; Williams L E; Demidecki A J; Wessels B W; Yan X W
Radiobiologic studies comparing Yttrium-90 irradiation and external beam irradiation in vitro.
International journal of radiation oncology, biology, physics 1991;20(4):715-22.
1990: Duda R B; Wong J Y; Paxton R J; Beatty B G; Williams L E; Shively J E; Beatty J D
Localization of intraperitoneal xenografts of human colon cancer by radiolabeled anti-CEA antibodies.
Journal of surgical oncology 1990;44(2):73-7.
1990: Presant C A; Blayney D; Proffitt R T; Turner A F; Williams L E; Nadel H I; Kennedy P; Wiseman C; Gala K; Crossley R J
Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes.
Lancet 1990;335(8701):1307-9.
1990: Buras R R; Beatty B G; Williams L E; Wanek P M; Harris J B; Hill L R; Beatty J D
Radioimmunotherapy of human colon cancer in nude mice.
Archives of surgery (Chicago, Ill. : 1960) 1990;125(5):660-4.
1990: Beatty J D; Williams L E; Yamauchi D; Morton B A; Hill L R; Beatty B G; Paxton R J; Merchant B; Shively J E
Presurgical imaging with indium-labeled anti-carcinoembryonic antigen for colon cancer staging.
Cancer research 1990;50(3 Suppl):922s-926s.
1990: Williams L E; Beatty B G; Beatty J D; Wong J Y; Paxton R J; Shively J E
Estimation of monoclonal antibody-associated 90Y activity needed to achieve certain tumor radiation doses in colorectal cancer patients.
Cancer research 1990;50(3 Suppl):1029s-1030s.
1989: Wong J Y; Mivechi N F; Paxton R J; Williams L E; Beatty B G; Beatty J D; Shively J E
The effects of hyperthermia on tumor carcinoembryonic antigen expression.
International journal of radiation oncology, biology, physics 1989;17(4):803-8.
1989: Williams L E; Wong J Y; Findley D O; Forell B W
Measurement and estimation of organ Bremsstrahlung radiation dose.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(8):1373-7.
1989: Beatty B G; Beatty J D; Williams L E; Paxton R J; Shively J E; O'Connor-Tressel M
Effect of specific antibody pretreatment on liver uptake of 111In-labeled anticarcinoembryonic antigen monoclonal antibody in nude mice bearing human colon cancer xenografts.
Cancer research 1989;49(6):1587-94.
1989: Wong J Y; Williams L E; Hill L R; Paxton R J; Beatty B G; Shively J E; Beatty J D
The effects of tumor mass, tumor age, and external beam radiation on tumor-specific antibody uptake.
International journal of radiation oncology, biology, physics 1989;16(3):715-20.
1989: Beatty J D; Hyams D M; Morton B A; Beatty B G; Williams L E; Yamauchi D; Merchant B; Paxton R J; Shively J E
Impact of radiolabeled antibody imaging on management of colon cancer.
American journal of surgery 1989;157(1):13-9.
1988: Presant C A; Proffitt R T; Turner A F; Williams L E; Winsor D; Werner J L; Kennedy P; Wiseman C; Gala K; McKenna R J
Successful imaging of human cancer with indium-111-labeled phospholipid vesicles.
Cancer 1988;62(5):905-11.
1988: Turner A F; Presant C A; Proffitt R T; Williams L E; Winsor D W; Werner J L
In-111-labeled liposomes: dosimetry and tumor depiction.
Radiology 1988;166(3):761-5.
1988: Williams L E; Duda R B; Proffitt R T; Beatty B G; Beatty J D; Wong J Y; Shively J E; Paxton R J
Tumor uptake as a function of tumor mass: a mathematic model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(1):103-9.
1987: Beatty J D; Philben V J; Beatty B G; Williams L E; Paxton R J; Shively J E; Duda R B; Vlahos W G; Werner J L; Sheibani K
Imaging of colon carcinoma with 111-indium-labeled anti-CEA monoclonal antibodies (Indacea) prior to surgery.
Journal of surgical oncology 1987;36(2):98-104.
1986: Beatty B G; Paxton R J; Sheibani K; Duda R B; Williams L E; Shively J E; Beatty J D
Testis imaging with 111In-labeled anticarcinoembryonic antigen monoclonal antibody: identification of carcinoembryonic antigen in normal germ cells.
Cancer research 1986;46(12 Pt 1):6503-8.
1986: Beatty J D; Duda R B; Williams L E; Sheibani K; Paxton R J; Beatty B G; Philben V J; Werner J L; Shively J E; Vlahos W G
Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody.
Cancer research 1986;46(12 Pt 1):6494-502.
1986: Duda R B; Beatty J D; Sheibani K; Williams L E; Paxton R J; Beatty B G; Shively J E; Vlahos W G; Werner J L; Kemeny M M
Imaging of human colorectal adenocarcinoma with indium-labeled anticarcinoembryonic antigen monoclonal antibody.
Archives of surgery (Chicago, Ill. : 1960) 1986;121(11):1315-9.
1986: Philben V J; Jakowatz J G; Beatty B G; Vlahos W G; Paxton R J; Williams L E; Shively J E; Beatty J D
The effect of tumor CEA content and tumor size on tissue uptake of indium 111-labeled anti-CEA monoclonal antibody.
Cancer 1986;57(3):571-6.
1985: Jakowatz J G; Beatty B G; Vlahos W G; Porudominsky D; Philben V J; Williams L E; Paxton R J; Shively J E; Beatty J D
High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
Cancer research 1985;45(11 Pt 2):5700-6.
1985: Paxton R J; Jakowatz J G; Beatty J D; Beatty B G; Vlahos W G; Williams L E; Clark B R; Shively J E
High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: improved method for the synthesis of diethylenetriaminepentaacetic acid conjugates.
Cancer research 1985;45(11 Pt 2):5694-9.
1985: Patel K R; Tin G W; Williams L E; Baldeschwieler J D
Biodistribution of phospholipid vesicles in mice bearing Lewis lung carcinoma and granuloma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(9):1048-55.
1984: Williams L E; Proffitt R T; Lovisatti L
Possible applications of phospholipid vesicles (liposomes) in diagnostic radiology.
The Journal of nuclear medicine and allied sciences 1984;28(1):35-45.
1983: Proffitt R T; Williams L E; Presant C A; Tin G W; Uliana J A; Gamble R C; Baldeschwieler J D
Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles.
Science (New York, N.Y.) 1983;220(4596):502-5.
1983: Proffitt R T; Williams L E; Presant C A; Tin G W; Uliana J A; Gamble R C; Baldeschwieler J D
Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1983;24(1):45-51.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Lawrence Williams

Research Profile (preview)

Chemicals & Drugs

Living Beings

Procedures

Concepts & Ideas

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Lawrence Williams (preview)

All Publications